300 participants
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-13
- Start Date:
- 2019-07-16
- Completion:
- 2028-03-30
Conditions
- Autoimmune Disease
- Crohn Disease
- Dermatomyositis
- Hematopoietic and Lymphoid Cell Neoplasm
- Inflammatory Bowel Disease
- Malignant Solid Neoplasm
- Multiple Sclerosis
- Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Sjogren Syndrome
- Systemic Lupus Erythematosus
- Systemic Scleroderma
- Ulcerative Colitis
Interventions
- PROCEDURE
- DRUG
- BIOLOGICAL
No Results Yet